r. Konstantina Mamali is a Dermatologist Venereologist, with valuable experience in Phlebology and Allergology and member, among others, of the European Academy of Dermatology and Venereology  and the German Society of Dermatosurgery. She studied at the school of Medicine of the Aristotle University in Thessaloniki and received her diploma in 2009. She finished the last year of her studies at the University Heinrich-Heine in Duesseldorf, Germany.

The latest “addition” to the professional medical team of  Cosmetic Derma Medicine group,  dermatologist-venereologist Dr Konstantina Mamali (right) with Dr Amalia Tsiatoura and Dr Anastasios Vekris.
    She did her practice at the departments of Dermatology, General Surgery, Gynecology, Pediatrics, Nephrology, Hematology-Oncology at the University clinic Heinrich-Heine in Duesseldorf. In the meantime (2009) she worked for a short time as a general doctor in the Department of Nephrology in the Polyclinic of Lamia. The 5 following years she specialized in Dermatology and worked at a private clinic of Dermatology, Phlebology & Allergology in Heiligenhaus, Germany. She also worked at a clinic of Dermatology and Allergology in Wiesbaden and the University clinic of Dermatology, Allergology and Venereal Diseases St. Josef Hospital-RUB in Bochum. In 2015 she got the specialty of Dermatologist-Venereologist.

    As a Dermatologist Venereologist, Dr Mamali has a vast experience in allergology, dermatosurgery and the occupational medicine. Today, Dr Mamali is deputy medical director of the department of Dermatology & Laser of Cosmetic Derma Medicine. Dr Konstantina Mamali speaks fluently Greek, English and German.

Postgraduate studies

Konstantina Mamali is a PhD candidate at the University RUB in Bochum in Germany. These are the titles of her PhD thesis:

  • Retrospective observational study of long-term efficacy and safety of continuous Fumaderm monotherapy in the treatment of psoriasis vulgaris
  • Decreased expression of ten-eleven translocation enzyme is associated with progressive disease and death in patients with cutaneous T cell lymphoma